Here, we demonstrate that deletion of Notch signaling within pro- and pre-B cells (using Mb1- and CD19-driven Cre recombinase, respectively) leads to a high incidence of T-cell lymphoma. The gene discussed is CD19; the disease is T-cell non-Hodgkin lymphoma.